Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics
Kari L. Ring(University of Virginia Health System), Karen H. Lu(Moffitt Cancer Center), W. Glenn McCluggage(Belfast Health and Social Care Trust), Samuel C. Mok(The University of Texas MD Anderson Cancer Center), David L. Kolin(Brigham and Women's Hospital), Kay J. Park(Memorial Sloan Kettering Cancer Center), Ann H. Klopp(The University of Texas MD Anderson Cancer Center), Anne M. Mills(Capital Meeting Planning), David S. Hong(The University of Texas MD Anderson Cancer Center), Ji Son(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Brooke E. Howitt(Cancer Institute (WIA)), Eliane Aoun(The University of Texas MD Anderson Cancer Center), Sammy Ferri‐Borgogno(The University of Texas MD Anderson Cancer Center), Jeffrey How(The University of Texas MD Anderson Cancer Center), Elizabeth D. Euscher(The University of Texas MD Anderson Cancer Center), Hyun Soo Kim(Pharmicell (South Korea)), Chika Awujo(The University of Texas MD Anderson Cancer Center), Lien Hoang(Vancouver General Hospital), Rachel N. Grisham(Memorial Sloan Kettering Cancer Center), Jelena Mirković(Tufts University)
Cited by 5
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
|Nature Communications|2016|785